Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 

Polls

Do you recommend a particular smart phone app to your diabetes patients?


Would you like to receive information on new diabetes smartphone apps?


In a recent study, Victoza lowered A1c by 1.5% and Bydureon by 1.3%. Will this affect your recommendations?


Do your type 2 patients not on insulin count their carbs and report back to you?


Will you switch your patients on other GLP-1's to Bydureon?


How many of your type 2 patients not on insulin test more than once a day?


How many of your diabetes patients are also suffering from depression?


Which new drug's approval are you most looking forward to in 2012?


How many of your patients will be successful with their New Year's resolutions?


Do your patients subtract the grams of fiber from the total carbs in their meals?


Which is the most important goal of pharmacologic treatment along with lifestyle change for T2DM patients?


Where is your diabetes education practice primarily based?


Should patients on a long-acting basal insulin of more than 30 units split the dose into twice a day?


Which ethnic food causes the biggest blood sugar problems for your patients?


Which barrier concerns you most regarding the use of SGLT-2 inhibitors in T2D patients?


Should insulin therapy be used earlier in the treatment of diabetes?


Would it make a difference if you were more active and discussed it with your patients?


What percent of your type 2 patients are on an incretin mimetic?


Have sulphonylureas become obsolete in your practice?


What percent of your patients still use the insulin vial and syringe instead of a pen?

Page 1 of 6

 
Diabetes In Control Advertisers
 
 
Cast Your Vote
Would you like to receive information on new diabetes smartphone apps?

Navigate Diabetes In Control
CME/CE of the Week
Presented by CardioCareLive
Category: Cardiology


Advertisement


Search Articles On Diabetes In Control